Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-08-28
2007-08-28
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S617000, C514S633000, C514S539000, C514S636000, C514S401000, C514S616000, C514S392000, C514S603000, C548S379400, C548S371400, C560S035000, C564S246000, C564S182000, C564S229000, C564S243000, C564S153000, C564S152000, C564S082000
Reexamination Certificate
active
10763953
ABSTRACT:
The present invention relates to the use of amidine compounds in the treatment of amyloid-related diseases. In particular, the invention relates to a method of treating or preventing an amyloid-related disease in a subject comprising administering to the subject a therapeutic amount of an amidine compound. Among the compounds for use according to the invention are those according to the following Formula, such that, when administered, amyloid fibril formation, neurodegeneration, or cellular toxicity is reduced or inhibited:
REFERENCES:
patent: 4324794 (1982-04-01), Tidwell et al.
patent: 4397863 (1983-08-01), Tidwell et al.
patent: 4515625 (1985-05-01), Burow, Jr.
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4619942 (1986-10-01), Tidwell et al.
patent: 4933347 (1990-06-01), Tidwell et al.
patent: 4940723 (1990-07-01), Tidwell et al.
patent: 4963589 (1990-10-01), Tidwell et al.
patent: 5202320 (1993-04-01), Tidwell et al.
patent: 5206236 (1993-04-01), Tidwell et al.
patent: 5246965 (1993-09-01), Main
patent: 5374548 (1994-12-01), Caras
patent: 5387742 (1995-02-01), Cordell
patent: 5399311 (1995-03-01), Kasai et al.
patent: 5428051 (1995-06-01), Tidwell et al.
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5451700 (1995-09-01), Morrissey et al.
patent: 5521189 (1996-05-01), Boykin et al.
patent: 5538845 (1996-07-01), Knops et al.
patent: 5547841 (1996-08-01), Marotta et al.
patent: 5552426 (1996-09-01), Lunn et al.
patent: 5574059 (1996-11-01), Regunathan et al.
patent: 5578631 (1996-11-01), Tidwell et al.
patent: 5594138 (1997-01-01), Dykstra et al.
patent: 5602172 (1997-02-01), Boykin et al.
patent: 5605811 (1997-02-01), Seubert et al.
patent: 5606058 (1997-02-01), Boykin et al.
patent: 5612363 (1997-03-01), Mohan et al.
patent: 5622955 (1997-04-01), Boykin et al.
patent: 5627184 (1997-05-01), Boykin et al.
patent: 5639755 (1997-06-01), Dykstra et al.
patent: 5643562 (1997-07-01), Kisilevsky et al.
patent: 5643935 (1997-07-01), Dykstra et al.
patent: 5667975 (1997-09-01), Dykstra et al.
patent: 5668166 (1997-09-01), Tidwell et al.
patent: 5668167 (1997-09-01), Tidwell et al.
patent: 5686456 (1997-11-01), Boykin et al.
patent: 5686477 (1997-11-01), Jarry et al.
patent: 5686496 (1997-11-01), Anderskewitz et al.
patent: 5720936 (1998-02-01), Wadsworth et al.
patent: 5721106 (1998-02-01), Maggio et al.
patent: 5723288 (1998-03-01), Dykstra et al.
patent: 5723495 (1998-03-01), Hall et al.
patent: 5726197 (1998-03-01), Clark et al.
patent: 5728375 (1998-03-01), Kisilevsky et al.
patent: 5731332 (1998-03-01), Anderskewitz et al.
patent: 5792782 (1998-08-01), Dykstra et al.
patent: 5811633 (1998-09-01), Wadsworth et al.
patent: 5817686 (1998-10-01), Dykstra et al.
patent: 5817687 (1998-10-01), Dykstra et al.
patent: 5840294 (1998-11-01), Kisilevsky et al.
patent: 5843980 (1998-12-01), Hall et al.
patent: 5871924 (1999-02-01), Yarus et al.
patent: 5935982 (1999-08-01), Dykstra et al.
patent: 5939440 (1999-08-01), Dykstra et al.
patent: 5972328 (1999-10-01), Kisilevsky et al.
patent: 5972969 (1999-10-01), Dykstra et al.
patent: 6008247 (1999-12-01), Boykin et al.
patent: 6017941 (2000-01-01), Dykstra et al.
patent: 6025398 (2000-02-01), Hall et al.
patent: 6037377 (2000-03-01), Anderskewitz et al.
patent: 6046226 (2000-04-01), Dykstra et al.
patent: 6127423 (2000-10-01), Anderskewitz et al.
patent: 6127554 (2000-10-01), Boykin et al.
patent: 6133281 (2000-10-01), Gonzalez-Cadavid et al.
patent: 6156779 (2000-12-01), Dykstra et al.
patent: 6172104 (2001-01-01), Tidwell et al.
patent: 6197824 (2001-03-01), Schromm et al.
patent: 6214883 (2001-04-01), Hall et al.
patent: 6294565 (2001-09-01), Dykstra et al.
patent: 6319944 (2001-11-01), Claiborne et al.
patent: 6326395 (2001-12-01), Tidwell et al.
patent: 6489365 (2002-12-01), Anderskewitz et al.
patent: 6625612 (2003-09-01), Tal et al.
patent: 6627647 (2003-09-01), Betageri
patent: 6635668 (2003-10-01), Tidwell et al.
patent: 2001/0044468 (2001-11-01), Hall et al.
patent: 2003/0083362 (2003-05-01), Boykin et al.
patent: 2003/0130303 (2003-07-01), Coe et al.
patent: 2003/0199521 (2003-10-01), Dykstra et al.
patent: 0518818 (1992-12-01), None
patent: 0601977 (1994-06-01), None
patent: 0941991 (1999-09-01), None
patent: 7-279092 (1995-10-01), None
patent: WO-93/16036 (1993-08-01), None
patent: WO-94/11341 (1994-05-01), None
patent: WO-95/19772 (1995-07-01), None
patent: WO-96/15126 (1996-05-01), None
patent: WO-96/28187 (1996-09-01), None
patent: WO-98/13037 (1998-04-01), None
patent: WO-98/40381 (1998-09-01), None
patent: WO-98/55454 (1998-12-01), None
patent: WO-00/04893 (2000-02-01), None
patent: WO-01/03680 (2001-01-01), None
patent: WO-01/03685 (2001-01-01), None
patent: WO-01/32159 (2001-05-01), None
patent: WO-01/46175 (2001-06-01), None
patent: WO-01/85093 (2001-11-01), None
patent: WO-02/02516 (2002-01-01), None
patent: WO-02/34715 (2002-05-01), None
patent: WO-02/36588 (2002-05-01), None
patent: WO-02/055025 (2002-07-01), None
patent: WO-02/058684 (2002-08-01), None
patent: WO-02/058697 (2002-08-01), None
patent: WO-02/062785 (2002-08-01), None
patent: WO-03/017994 (2003-03-01), None
patent: WO 03017994 (2003-03-01), None
patent: WO-03/103598 (2003-12-01), None
patent: WO 03103598 (2003-12-01), None
patent: WO-2005/033065 (2005-04-01), None
patent: WO 2005033065 (2005-04-01), None
patent: WO-2005/079780 (2005-09-01), None
Citron, M. Nature Reviews Neuroscience 2004, 5, 677-685.
Tanzi, R.E. Nature Medicine 1996, 2(1), 31-32.
Masters et al. Proc. Natl. Acad. Sci. USA 1985, 82, 4245-4249.
Askanas V, et al., “New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies.” Curr. Opin. Rheumatol. 7(6), 486-96 (Nov. 1995).
Askanas V, et al., “Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle.” Proc. Nat'l Acad. Sci. U.S.A. 93(3), 1314-19 (Feb. 1996).
Bailly, C, et al., “Sequence-selective binding to DNA of bis(amidinophenoxy)alkanes related to propamidine and pentamidine,” Biochem J. Apr. 1, 1997;323 ( Pt 1):23-31.
Baldwin, et al., “Molecular Biology, Genetics and Protein Chemistry of Prion Diseases,” Research Advances in Alzheimer's Disease and Related Disorders, John Wiley and Sons, New York, 757-773 (1995).
Bayer, TA, et al., “Key factors in Alzheimer's disease: β amyloid precursor protein processing, metabolism and intraneuronal transport,” Brain Pathology 11, 111 (2001).
Beekes, M, et al., “Western blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method.” J. Gen. Virol. 76(Pt 10), 2567-76 (Oct. 1995).
Benson, DA, et al., “GenBank,” Nucl. Acids Res. 28(1):15-18 (2000).
Berge, et al., “Pharmaceutical salts.” J. Pharm. Sci. 66(1), 1-19 (Jan. 1977).
Bilik P., et al., “Novel dications with unfused aromatic systems: trithiophene and trifuran derivatives of furimidazoline,” CHEMBIOCHEM 2(78), 559-69 (2001).
Boado, R.J., et al., “Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS,” J. Pharm. Sci. 87(11), 1308-15 (Nov. 1998).
Bohmann, B., et al., “Self-assembly of β-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates,” J. Struct. Biol. 130(2-3), 232-46 (Jun. 2000).
Boykin, D. W et al., “Anti-Pneumocystis carinii pneumonia activity of dicationic diaryl methylpyrimidines” European Journal of Medicinal Chemistry (1997), 32(12), 965-972.
Cardin, A.D, et al., “Molecular modeling of protein-glycosaminoglycan interactions,” Arteriosclerosis. 9(1), 21-32 (Jan.-Feb. 1989).
Caughey, GH, et al., “Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases,” J Pharmacol Exp Ther. Feb. 1993;264(2):676-82.
Chauhan, P.M.S. et al., “Antiparasi
Kong Xianqi
Migneault David
Wu Xinfu
Lahive & Cockfield LLP
Neurochem (International) Limited
Nolan Jason M.
Saeed Kamal A.
LandOfFree
Amidine derivatives for treating amyloidosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidine derivatives for treating amyloidosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidine derivatives for treating amyloidosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3891980